Table: begin end state 1 9 cytoplasmic 10 29 transmembrane 30 40 non-cytoplasmic 41 60 transmembrane 61 92 cytoplasmic 93 117 transmembrane 118 124 non-cytoplasmic 125 144 transmembrane 145 150 cytoplasmic 151 176 transmembrane 177 201 non-cytoplasmic 202 222 transmembrane 223 233 cytoplasmic 234 256 transmembrane 257 281 non-cytoplasmic 282 310 transmembrane 311 330 cytoplasmic 331 352 transmembrane 353 357 non-cytoplasmic 358 382 transmembrane 383 394 cytoplasmic 395 413 transmembrane 414 418 non-cytoplasmic 419 437 transmembrane 438 448 cytoplasmic 449 469 transmembrane 470 475 non-cytoplasmic
Input: >Pf6N2E2_2906 MPQPIEKLPLGALIALVVGSMIGGGIFSLPQNMAARADVGAVLIGWAITAIGMLTLAFVF QTLANRKPQLNSGVYAYAKAGFGDYMGFSSAWGYWISAWLGNVGYFVLLFSTLGYFFPVF GQGNTPVAIGCASLLLWAVHFLVLRGIQEAAFINLVTTVAKVVPLLMFVVMAAVAFKAEV FTRDIWGAMNPDLGSVMDQVRNMMLVTVFVFIGIEGASVYSARAERRADVGRATVIGFLG VLALLVLVNVLSLGVMSQRELAQLQNPSLAGVLEHIVGPWGALLISLGLAVSLLGALLSW ALLCAEILYATARDKTMPAFLTKENANRAPVNALWLTNGMIQLFLLITLFSAGTYTSLIY LASSMILVPYLWSAAYAVLLCARGETYEQGSARRMKDLCIGGVALCYAVWLLYAGGVKYL LLSALLYAPGVILFAQAKREQGQPLFTHVEKGVFACVMAGAGGAAYGLYSGFLEL
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server